Effect of Treatment With Tabalumab, a B Cell-Activating Factor Inhibitor, on Highly Sensitized Patients With End-Stage Renal Disease Awaiting Transplantation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Treatment With Tabalumab, a B Cell-Activating Factor Inhibitor, on Highly Sensitized Patients With End-Stage Renal Disease Awaiting Transplantation
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume 16, Issue 4, Pages 1266-1275
Publisher
Wiley
Online
2016-01-19
DOI
10.1111/ajt.13557
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neutralizing BAFF/APRIL With Atacicept Prevents Early DSA Formation and AMR Development in T Cell Depletion Induced Nonhuman Primate AMR Model
- (2015) J. Kwun et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The New Kidney Allocation System (KAS) and the Highly Sensitized Patient: Expect the Unexpected
- (2014) R. A. Bray et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Risk factors of sensitization to human leukocyte antigen in end-stage renal disease patients
- (2014) Shih-Yuan Hung et al. HUMAN IMMUNOLOGY
- B Cell Depletion Curtails CD4+ T Cell Memory and Reduces Protection against Disseminating Virus Infection
- (2014) I. Misumi et al. JOURNAL OF IMMUNOLOGY
- A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate
- (2013) Mark C Genovese et al. ANNALS OF THE RHEUMATIC DISEASES
- The effectiveness of the combination of rituximab and high-dose immunoglobulin in the immunomodulation of sensitized kidney transplant candidates
- (2013) Tim Taber et al. CLINICAL TRANSPLANTATION
- Elevated Pretransplantation Soluble BAFF Is Associated With an Increased Risk of Acute Antibody-Mediated Rejection
- (2013) Gemma Banham et al. TRANSPLANTATION
- Analysis of Anti-HLA Antibodies in Sensitized Kidney Transplant Candidates Subjected to Desensitization with Intravenous Immunoglobulin and Rituximab
- (2013) Andrew L. Lobashevsky et al. TRANSPLANTATION
- Peripheral B-Cell Phenotype and BAFF Levels are Associated With HLA Immunization in Patients Awaiting Kidney Transplantation
- (2013) Renaud Snanoudj et al. TRANSPLANTATION
- Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients
- (2011) M. D. Stegall et al. AMERICAN JOURNAL OF TRANSPLANTATION
- BAFF inhibition: A new class of drugs for the treatment of autoimmunity
- (2011) Zheng Liu et al. EXPERIMENTAL CELL RESEARCH
- Desensitization in HLA-Incompatible Kidney Recipients and Survival
- (2011) Robert A. Montgomery et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eculizumab, Bortezomib and Kidney Paired Donation Facilitate Transplantation of a Highly Sensitized Patient Without Vascular Access
- (2010) B. E. Lonze et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Sensitized renal transplant recipients: current protocols and future directions
- (2010) James Gloor et al. Nature Reviews Nephrology
- Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney Transplantation
- (2010) Ashley A. Vo et al. TRANSPLANTATION
- Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
- (2008) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started